journal
MENU ▼
Read by QxMD icon Read
search

Journal of Crohn's & Colitis

journal
https://www.readbyqxmd.com/read/28645143/fermentable-carbohydrates-in-ibd-trouble-brewing
#1
Giles Major
No abstract text is available yet for this article.
June 21, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28633443/nod2-genetic-variants-predispose-one-of-two-familial-adenomatous-polyposis-siblings-to-pouchitis-through-microbiome-dysbiosis
#2
Kathleen M Schieffer, Justin R Wright, Leonard R Harris, Sue Deiling, Zhaohai Yang, Regina Lamendella, Gregory S Yochum, Walter A Koltun
Background and Aims: Individuals with familial adenomatous polyposis (FAP) may undergo a total proctocolectomy with ileal pouch-anal anastomosis (IPAA) to surgically treat their disease. Inflammation of the ileal pouch, termed pouchitis, is uncommon in FAP patients but prevalent in patients who received IPAA for ulcerative colitis, a type of inflammatory bowel disease (IBD). Methods and Results: We report on two FAP siblings, living in the same household, who underwent IPAA surgery within one week of each other...
June 19, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28605520/serial-tuberculosis-screening-in-inflammatory-bowel-disease-patients-under-anti-tnf%C3%AE-therapy
#3
Cândida Abreu, Joana Afonso, Cláudia Camila Dias, Rogério Ruas, António Sarmento, Fernando Magro
Background and aims: One of the adverse effects of the tumour necrosis factor-α monoclonal antibodies for the treatment of immune-mediated inflammatory diseases is a higher propensity for tuberculosis development. The aim of this study was to explore the utility and sensitivity of serial tuberculosis screening during anti-TNFα treatment. Methods: A cohort of 46 inflammatory bowel disease patients on infliximab was prospectively recruited and followed for 26 months...
June 9, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28605483/vedolizumab-in-pediatric-inflammatory-bowel-disease-a-retrospective-multi-center-experience-from-the-paediatric-ibd-porto-group-of-espghan
#4
Oren Ledder, Amit Assa, Arie Levine, Johanna C Escher, Lissy de Ridder, Frank Ruemmele, Neil Shah, Ron Shaoul, Victorien M Wolters, Astor Rodrigues, Holm H Uhlig, Carsten Posovsky, Kaija-Leena Kolho, Christian Jakobsen, Shlomi Cohen, Dror S Shouval, Tim de Meij, Javier Martin-de-Carpi, Lisa Richmond, Jiri Bronsky, Mira Friedman, Dan Turner
Background: Vedolizumab, an anti-integrin antibody, has proven to be effective in adults with Inflammatory Bowel Disease (IBD), but the data in pediatrics are limited. We describe the short-term effectiveness and safety of vedolizumab in a European multi-center pediatric IBD cohort. Method: Retrospective review of children (2-18 years) treated with vedolizumab from 19 centers affiliated with the Paediatric IBD Porto group of ESPGHAN. Primary outcome was week 14 corticosteroid-free remission (CFR)...
June 9, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28575273/positioning-ustekinumab-in-crohn-s-disease-from-clinical-evidence-to-clinical-practice
#5
Silvio Danese, Stefanos Bonovas, Laurent Peyrin-Biroulet
Biological medicines have revolutionized the treatment of Crohn's disease (CD). Yet, the management of patients not responding to tumor necrosis factor (TNF) antagonists remains a clinical challenge. Ustekinumab is a human monoclonal antibody blocking the biological activity of interleukins 12 and 23, which regulate the immune system and immune-mediated inflammatory disorders. It has recently been approved for the treatment of adult patients with moderately to severely active CD, who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a TNF antagonist, or have medical contraindications to such therapies...
June 2, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28575481/occurrence-of-anaemia-in-the-first-year-of-inflammatory-bowel-disease-in-a-european-population-based-inception-cohort-an-ecco-epicom-study
#6
Johan Burisch, Zsuzsanna Vegh, Konstantinnos H Katsanos, Dimitrios K Christodoulou, Daniela Lazar, Adrian Goldis, Colm O'Morain, Alberto Fernandez, Santos Pereira, Sally Myers, Shaji Sebastian, Natalia Pedersen, Jóngerð Olsen, Kári Rubek Nielsen, Doron Schwartz, Selwyn Odes, Sven Almer, Jonas Halfvarson, Niksa Turk, Silvja Cukovic-Cavka, Inna Nikulina, Elena Belousova, Dana Duricova, Martin Bortlik, Olga Shonová, Riina Salupere, Louisa Barros, Fernando Magro, Laimas Jonaitis, Limas Kupcinskas, Svetlana Turcan, Ioannis Kaimakliotis, Karin Ladefoged, Karen Kudsk, Vibeke Andersen, Ida Vind, Niels Thorsgaard, Pia Oksanen, Pekka Collin, Giulia Dal Piaz, Alessia Santini, Ola Niewiadomski, Sally Bell, Bjørn Moum, Naila Arebi, Jens Kjeldsen, Katrine Carlsen, Ebbe Langholz, Peter Laszlo Lakatos, Pia Munkholm, Lars Ulrik Gerdes, Jens Frederik Dahlerup
Background and aims: Anaemia is an important complication of inflammatory bowel disease (IBD). The aim of this study was to determine the prevalence of anaemia and the practice of anaemia screening during the first year following diagnosis in a European prospective population-based inception cohort. Methods: Newly diagnosed IBD patients were included and followed prospectively for one year in 29 European and 1 Australian centre. Clinical data including demographics, medical therapy, surgery and blood samples were collected...
May 31, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28575325/exclusive-enteral-nutrition-therapy-in-pediatric-crohn-s-disease-results-in-long-term-avoidance-of-corticosteroids-results-of-a-propensity-score-matched-cohort-analysis
#7
Jessica Connors, Sana Basseri, Amy Grant, Nick Giffin, Gamal Mahdi, Angela Noble, Mohsin Rashid, Anthony Otley, Johan Van Limbergen
Background & Aims: Exclusive enteral nutrition (EEN) is recommended as first-line induction therapy for pediatric Crohn's disease (CD) although corticosteroids (CS) are still used commonly. Our aim was to compare short- and long-term disease outcomes of pediatric CD patients initially managed with either EEN or CS. Methods: Medical records of newly-diagnosed pediatric CD patients treated with EEN or CS as induction therapy were retrospectively reviewed. To minimize selection bias inherent in observational cohort studies, propensity analysis was carried out...
May 27, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28575290/bringing-the-mucosa-to-heal-with-vedolizumab-in-patients-with-inflammatory-bowel-disease
#8
Satimai Aniwan, Edward V Loftus
No abstract text is available yet for this article.
May 27, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28575164/genetic-mouse-models-with-intestinal-specific-tight-junction-deletion-resemble-an-ulcerative-colitis-phenotype
#9
Wolfgang Stremmel, Simone Staffer, Mathias Jochen Schneider, Hongying Gan-Schreier, Andreas Wannhoff, Nicole Stuhrmann, Annika Gauss, Hartwig Wolburg, Anne Mahringer, Alexander Swidsinski, Thomas Efferth
Background and Aims: A key pathogenetic feature of ulcerative colitis(UC) is an intrinsic low mucus phosphatidylcholine(PC) content. Recently, a paracellular transport for PC across tight junctions(TJ) was described, suggesting TJ disturbance as cause of diminished luminal PC transport. Therefore we aimed to generate mutant mice with TJ deletion to evaluate whether an UC phenotype developed. Methods: CL57BL/6 control wild-type mice were compared to mutant mice with tamoxifen-induced villin-Cre dependent intestinal deletion of kindlin 1 and 2...
May 27, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28789473/quality-items-required-for-running-a-paediatric-inflammatory-bowel-disease-centre-an-ecco-paper
#10
Dan Turner, Adam Carle, Steven J Steiner, Peter A Margolis, Richard B Colletti, Richard K Russell, Arie Levine, Kaija-Leena Kolho, Frank M Ruemmele
Background: The importance of a holistic approach with a comprehensive multidisciplinary team, including nutritional and psychosocial support, is becoming well recognised as a key contributor to optimal care in paediatric inflammatory bowel disease [IBD]. The Paediatric committee of ECCO [P-ECCO] aimed to determine important components that would contribute to quality of care in a paediatric IBD centre [henceforth 'quality items']. Methods: First, a list of items has been generated by a Delphi group of 111 international paediatric IBD experts...
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28379306/anal-neoplasia-in-inflammatory-bowel-disease-classification-proposal-epidemiology-carcinogenesis-and-risk-management-perspectives
#11
Andrew Wisniewski, Jean-Francois Fléjou, Laurent Siproudhis, Laurent Abramowitz, Magali Svrcek, Laurent Beaugerie
Patients with inflammatory bowel disease [IBD] may develop, similarly to individuals from general population, rare cases of human papilloma virus [HPV]-related anal canal squamous cell carcinoma [SCC] and intra-epithelial precursor lesions, as well as very rare cases of anal canal adenocarcinoma. Patients with chronic perianal Crohn's disease [CD] are at substantial risk of developing SCC or adenocarcinoma from the fistula-lining epithelium, as well as SCC or adenocarcinoma arising from chronic anorectal ulcerations or strictures...
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28369422/ileal-pouch-anal-anastomosis-for-dysplasia-or-cancer-complicating-inflammatory-bowel-disease-is-total-mesorectal-excision-always-mandatory-an-analysis-of-36-consecutive-patients
#12
Chloé Coton, Léon Maggiori, Diane Mège, Clotilde Naudot, Justine Prost À la Denise, Yves Panis
Background and Aims: The extent of lymph node harvesting during surgery for colorectal neoplasm [dysplasia and/or cancer] complicating inflammatory bowel disease [IBD] is a matter of debate. This study aimed to assess the risk of invasive rectal cancer in patients undergoing ileal pouch-anal anastomosis [IPAA] for colonic neoplasm complicating IBD, and thus to clarify whether a systematic total mesorectal excision [TME] should be systematically performed, or not, in those patients. Methods: From 1998 to 2015, all patients who underwent IPAA for colorectal neoplasm complicating IBD were included...
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28369299/mesalamine-enemas-for-induction-of-remission-in-oral-mesalamine-refractory-pediatric-ulcerative-colitis-a-prospective-cohort-study
#13
Arie Levine, Baruch Yerushalmi, Michal Kori, Efrat Broide, Yael Mozer-Glassberg, Ron Shaoul, Kaija-Leena Kolho, Eyal Shteyer, Hussein Shamaly, Oren Ledder, Shlomi Cohen, Sarit Peleg, Chen Sarbagili Shabat, Gili Focht, Ebby Shachmon, Mona Boaz, Avi On, Dan Turner
Background: Paediatric ulcerative colitis [UC] is more extensive than adult disease, and more often refractory to mesalamine. However, no prospective trials have evaluated mesalamine enemas for inducing remission in children. Our goal was to evaluate the ability of mesalamine enemas to induce remission in mild to moderate paediatric UC refractory to oral mesalamine. Methods: This was an open-label arm of a previously reported randomised controlled trial of once-daily mesalamine in active paediatric UC [MUPPIT trial]...
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28333358/cancer-risk-in-the-early-stages-of-inflammatory-bowel-disease-in-korean-patients-a-nationwide-population-based-study
#14
Yoon Suk Jung, Minkyung Han, Sohee Park, Won Ho Kim, Jae Hee Cheon
Background and Aims: The association between inflammatory bowel disease [IBD] and cancer remains poorly defined in Asian populations. Therefore, we conducted a nationwide population-based study to determine the cancer risk in Korean patients with IBD. Methods: Using the National Health Insurance claims data, we collected data on patients diagnosed with IBD (5595 Crohn's disease [CD] and 10 049 ulcerative colitis [UC]) from 2011 to 2014. Standardized incidence ratios [SIRs] of overall and site-specific cancers in IBD patients in comparison with the general population were calculated...
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28333341/systemic-administration-of-sialorphin-attenuates-experimental-colitis-in-mice-via-interaction-with-mu-and-kappa-opioid-receptors
#15
M Salaga, A Mokrowiecka, D Jacenik, A I Cygankiewicz, E Malecka-Panas, R Kordek, W M Krajewska, M K Sobocinska, E Kamysz, J Fichna
Background and Aims: Pharmacological treatment and/or maintenance of remission in inflammatory bowel disease [IBD] is currently one of the biggest challenges in the field of gastroenterology. Here we aimed to assess the anti-inflammatory effect and the mechanism of action of sialorphin, the natural blocker of the endogenous opioid peptide-degrading enzymes neprilysin [NEP] and aminopeptidase N [APN], in mouse models of IBD and the changes in the expression of these enzymes in IBD patients...
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28333335/saccharomyces-boulardii-cncm-i-745-restores-intestinal-barrier-integrity-by-regulation-of-e-cadherin-recycling
#16
Chloé Terciolo, Aurélie Dobric, Mehdi Ouaissi, Carole Siret, Gilles Breuzard, Françoise Silvy, Bastien Marchiori, Sébastien Germain, Renaté Bonier, Adel Hama, Roisin Owens, Dominique Lombardo, Véronique Rigot, Frédéric André
Background and Aims: Alteration in intestinal permeability is the main factor underlying the pathogenesis of many diseases affecting the gut, such as inflammatory bowel disease [IBD]. Characterization of molecules targeting the restoration of intestinal barrier integrity is therefore vital for the development of alternative therapies. The yeast Saccharomyces boulardii CNCM I-745 [Sb], used to prevent and treat antibiotic-associated infectious and functional diarrhea, may have a beneficial effect in the treatment of IBD...
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28333328/the-time-course-of-diagnostic-delay-in-inflammatory-bowel-disease-over-the-last-sixty-years-an-italian-multicentre-study
#17
Laura Cantoro, Antonio Di Sabatino, Claudio Papi, Giovanna Margagnoni, Sandro Ardizzone, Paolo Giuffrida, Diana Giannarelli, Alessandro Massari, Rita Monterubbianesi, Marco Vincenzo Lenti, Gino Roberto Corazza, Anna Kohn
Background and Aims: Inflammatory bowel disease [IBD] patients are still under-diagnosed or diagnosed with serious delay. We examined whether diagnostic delay [DD] in IBD has changed over the last 60 years, and explored the risk factors of longer DD. Methods: In total, 3392 IBD patients recorded in the registry of four IBD Italian centres were divided according to the year of diagnosis into a historical cohort [HC: 1955-84] and modern cohort [MC: 1985-2014]. DD, i...
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28333291/corrigendum-the-future-of-janus-kinase-inhibitors-in-inflammatory-bowel-disease
#18
(no author information available yet)
No abstract text is available yet for this article.
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28333288/exposure-efficacy-relationships-for-vedolizumab-induction-therapy-in-patients-with-ulcerative-colitis-or-crohn-s-disease
#19
Maria Rosario, Jonathan L French, Nathanael L Dirks, Serap Sankoh, Asit Parikh, Huyuan Yang, Silvio Danese, Jean-Frédéric Colombel, Michael Smyth, William J Sandborn, Brian G Feagan, Walter Reinisch, Bruce E Sands, Miguel Sans, Irving Fox
Background and Aims: A positive relationship between vedolizumab trough serum concentrations and clinical outcomes in patients with ulcerative colitis [UC] or Crohn's disease [CD] has been reported. Here we further explore exposure-efficacy relationships for vedolizumab induction therapy in post hoc analyses of GEMINI study data. Methods: Vedolizumab trough concentrations at Week 6 or 10 were grouped in quartiles and clinical outcome rates calculated. Exposure-efficacy relationships at Week 6 and potential baseline covariate effects were explored using logistic regression and individual predicted cumulative average concentration through Week 6 [Caverage] as exposure measure...
August 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28333281/erratum-use-of-digital-technology-to-boost-patient-recruitment-in-inflammatory-bowel-disease-clinical-trials
#20
(no author information available yet)
No abstract text is available yet for this article.
August 1, 2017: Journal of Crohn's & Colitis
journal
journal
41775
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"